STAT3 and p53: Dual Target for Cancer Therapy
The tumor suppressor p53 is considered the “guardian of the genome” that can protect cells against cancer by inducing cell cycle arrest followed by cell death. However, STAT3 is constitutively activated in several human cancers and plays crucial roles in promoting cancer cell proliferation and survi...
Main Authors: | Thu-Huyen Pham, Hyo-Min Park, Jinju Kim, Jin Tae Hong, Do-Young Yoon |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/8/12/637 |
Similar Items
-
The Role of p53 Signaling in Colorectal Cancer
by: Magdalena C. Liebl, et al.
Published: (2021-04-01) -
The p53 Pathway in Glioblastoma
by: Ying Zhang, et al.
Published: (2018-09-01) -
Recent Synthetic Approaches towards Small Molecule Reactivators of p53
by: Jerson L. Silva, et al.
Published: (2020-04-01) -
Depletion of R270C Mutant p53 in Osteosarcoma Attenuates Cell Growth but Does Not Prevent Invasion and Metastasis In Vivo
by: Takatsune Shimizu, et al.
Published: (2022-11-01) -
The Status of p53 Oligomeric and Aggregation States in Cancer
by: Guilherme A. P. de Oliveira, et al.
Published: (2020-04-01)